기사 (149건) 리스트형 웹진형 타일형 Novo Nordisk Ozempic – Lilly Trulicity, 1Q KRW 2.2 trillion neck and neck Novo Nordisk Ozempic – Lilly Trulicity, 1Q KRW 2.2 trillion neck and neck Dong-A ST’s cash equivalents exceed KRW 200 billion, overtaking Yuhan Dong-A ST’s cash equivalents exceed KRW 200 billion, overtaking Yuhan Listed pharmaceutical companies shrink 1Q retained earnings Listed pharmaceutical companies shrink 1Q retained earnings 1Q sales of comprehensive cold medicineㆍantipyretics surged 1Q sales of comprehensive cold medicineㆍantipyretics surged Listed pharmaceutical companies’ exports soared in the first quarter, GC PharmaㆍYuhan ↑KRW 50 billion Listed pharmaceutical companies’ exports soared in the first quarter, GC PharmaㆍYuhan ↑KRW 50 billion HumasisㆍSeegene quarterly operating profit exceeded KRW 200 billion, ↑KRW 100 billion for Samsung BiologicsㆍCelltrion HumasisㆍSeegene quarterly operating profit exceeded KRW 200 billion, ↑KRW 100 billion for Samsung BiologicsㆍCelltrion Novartis KymriahㆍBiogen Spinraza, growth freeze due to latecomers Novartis KymriahㆍBiogen Spinraza, growth freeze due to latecomers Global big pharma grows its sales amid the spread of COVID-19 Global big pharma grows its sales amid the spread of COVID-19 Korean Top pharmaceutical companies’ sales of OTC drugs expanded due to the COVID-19 pandemic Korean Top pharmaceutical companies’ sales of OTC drugs expanded due to the COVID-19 pandemic Big 5 pharmaceutical companies post 19.7% average sales growth, operating profit and net profit surge Big 5 pharmaceutical companies post 19.7% average sales growth, operating profit and net profit surge Korea’s exports of bio-health marches to a new record, contracting from March Korea’s exports of bio-health marches to a new record, contracting from March Korea Q1 Pharmaceutical products exports, $300 million surplus to Australia and $100 million to Taiwan Korea Q1 Pharmaceutical products exports, $300 million surplus to Australia and $100 million to Taiwan 처음처음이전이전이전111213끝끝